Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India
· Delayed Price · Currency is INR 1,300.80
-48.15 (-3.57%)
Feb 21, 2025, 3:29 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 367.07 billion as of February 21, 2025. Its market cap has increased by 48.29% in one year.
Market Cap
367.07B
Enterprise Value
366.67B
Revenue
139.61B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,300.80
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 367.07B, an increase of 31,838.51%. That is a compound annual growth rate of 27.51%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,943.91B |
| Divi's Laboratories | 1,528.32B |
| Cipla | 1,191.84B |
| Mankind Pharma | 960.38B |
| Apollo Hospitals Enterprise | 908.37B |
| Zydus Lifesciences | 890.87B |
| Aurobindo Pharma | 647.68B |
| Alkem Laboratories | 550.15B |